Articoli con mandati relativi all'accesso pubblico - Philippe MARCHETTIUlteriori informazioni
Non disponibili pubblicamente: 4
Concise synthesis of lamellarin alkaloids by C–H/N–H activation: evaluation of metal catalysts in oxidative alkyne annulation
R Mei, SK Zhang, L Ackermann
Synlett 28 (14), 1715-1718, 2017
Mandati: European Commission
Metabolic features of melanoma: a gold mine of new therapeutic targets?
P Marchetti, P Guerreschi, J Kluza, L Mortier
Current Cancer Drug Targets 14 (4), 357-370, 2014
Mandati: Swiss Cancer League
Patient-derived tumor xenograft strategies for informed management of patients with metastatic melanoma
A Qassemyar, PE Gabert, J Kluza, V Duquennoy-Martinot, L Mortier, ...
Melanoma Research 26 (3), 245-253, 2016
Mandati: Swiss Cancer League
Apoptosis and senescence are triggered by Lamellarin-D in cancer cells
C Ballot, A Martoriati, J Kluza, P Formstecher, P Marchetti
European Journal of Cancer Supplements 6 (9), 98-99, 2008
Mandati: National Institute of Health and Medical Research, France
Disponibili pubblicamente: 30
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
MS Trabelsi, M Daoudi, J Prawitt, S Ducastel, V Touche, SI Sayin, ...
Nature communications 6 (1), 7629, 2015
Mandati: National Institute of Health and Medical Research, France, UK Medical …
Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non‐transformed and cancer cells
P Marchetti, Q Fovez, N Germain, R Khamari, J Kluza
The FASEB Journal 34 (10), 13106-13124, 2020
Mandati: Swiss Cancer League
Mitochondrial oxidative stress is the Achille's heel of melanoma cells resistant to Braf-mutant inhibitor
P Corazao-Rozas, P Guerreschi, M Jendoubi, F André, A Jonneaux, ...
Oncotarget 4 (11), 1986, 2013
Mandati: National Institute of Health and Medical Research, France
Lactate inhibits the pro-inflammatory response and metabolic reprogramming in murine macrophages in a GPR81-independent manner
A Errea, D Cayet, P Marchetti, C Tang, J Kluza, S Offermanns, JC Sirard, ...
PloS one 11 (11), e0163694, 2016
Mandati: National Institute of Health and Medical Research, France, Government of …
Mitochondrial electron transport is the cellular target of the oncology drug elesclomol
RK Blackman, K Cheung-Ong, M Gebbia, DA Proia, S He, J Kepros, ...
PloS one 7 (1), e29798, 2012
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D
C Ballot, J Kluza, S Lancel, A Martoriati, SM Hassoun, L Mortier, ...
Apoptosis 15, 769-781, 2010
Mandati: National Institute of Health and Medical Research, France
Lipid metabolism and resistance to anticancer treatment
N Germain, M Dhayer, M Boileau, Q Fovez, J Kluza, P Marchetti
Biology 9 (12), 474, 2020
Mandati: National Institute of Health and Medical Research, France, Swiss Cancer League
Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitors
R Khamari, A Trinh, PE Gabert, P Corazao-Rozas, S Riveros-Cruz, ...
Cell death & disease 9 (3), 325, 2018
Mandati: National Institute of Health and Medical Research, France, Swiss Cancer League
Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D
C Ballot, J Kluza, A Martoriati, U Nyman, P Formstecher, B Joseph, ...
Molecular cancer therapeutics 8 (12), 3307-3317, 2009
Mandati: National Institute of Health and Medical Research, France
Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway
MA Gallego, C Ballot, J Kluza, N Hajji, A Martoriati, L Castera, C Cuevas, ...
Oncogene 27 (14), 1981-1992, 2008
Mandati: National Institute of Health and Medical Research, France
Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors
P Corazao-Rozas, P Guerreschi, F André, PE Gabert, S Lancel, ...
Oncotarget 7 (26), 39473, 2016
Mandati: Swiss Cancer League
Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells
J Kluza, M Jendoubi, C Ballot, A Dammak, A Jonneaux, T Idziorek, S Joha, ...
PLoS One 6 (7), e21924, 2011
Mandati: National Institute of Health and Medical Research, France
Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib
A Lehraiki, M Cerezo, F Rouaud, P Abbe, M Allegra, J Kluza, P Marchetti, ...
Cell discovery 1 (1), 1-13, 2015
Mandati: National Institute of Health and Medical Research, France
Current advances in 3D bioprinting for cancer modeling and personalized medicine
N Germain, M Dhayer, S Dekiouk, P Marchetti
International journal of molecular sciences 23 (7), 3432, 2022
Mandati: Swiss Cancer League
AMP-activated protein kinase is essential for the maintenance of energy levels during synaptic activation
C Marinangeli, S Didier, T Ahmed, R Caillerez, M Domise, C Laloux, ...
IScience 9, 1-13, 2018
Mandati: Research Foundation (Flanders), Swiss Cancer League
Melanoma metabolism contributes to the cellular responses to MAPK/ERK pathway inhibitors
P Marchetti, A Trinh, R Khamari, J Kluza
Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (4), 999-1005, 2018
Mandati: National Institute of Health and Medical Research, France, Swiss Cancer League
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software